Homburger has advised Credit Suisse and UBS Switzerland in connection with the financing of Farner Consulting in support of its international buy-&-build strategy. Farner Consulting, together with its subsidiaries Rod and DU DA,
Tags :Homburger
Nestlé has issued CHF 930 million Bonds which will be listed on the SIX Swiss Exchange. The transaction consists of a CHF 360 million tranche due November 2025 (Tranche 1), a CHF 310 million tranche due November 2029 (Tranche 2) and a
In November 2021, AMAG Leasing, a subsidiary of AMAG Group, established its CHF 1.5 bn Auto Covered Bond Programme irrevocably guaranteed as to payments of interest and principal by AMAG Leasing Auto Covered Bond. Recently, on November 3, 2022,
H.I.G. Capital, a leading global investment firm with USD 52 bn of equity capital under management, announced that one of its affiliates has completed the acquisition of Celerion Holdings, a leading full-service provider of
StoneX Group, a global financial services company, announced that it had acquired Cotton Distributors (CDI). CDI operates a global cotton merchant business and is headquartered in Lausanne with an office in Brazil. Homburger advised StoneX
LatticeFLow, an ETH spin-off pioneering in robust artificial intelligence (AI) having built a system that can automatically find and fix AI data and model errors, announced a USD 12 m Series A funding round led by
PHOENIX Pharma Switzerland, a subsidiary of the family-owned PHOENIX group, and Voigt Holding announced that they agreed to establish a 50/50-joint venture to combine their pharmaceutical distribution services and pre-wholesale activities. The closing of the
Accelleron Industries and Turbo Systems Schweiz have entered into a CHF 450 m credit facilities agreement with Credit Suisse Switzerland as mandated lead arranger, agent and original lender. Based in Baden, Accelleron is a renowed company
MCH Group, a renowed international live marketing company, has announced the result of its rights offering. The company will realise gross proceeds totalling CHF 76.9 million. MCH Group continues to have a stable, long-term anchor shareholder
VectivBio Holding, a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, has announced the pricing of a USD 125 m underwritten offering of ordinary shares. The underwritten offering consists of 16,700,000 ordinary shares at
